非小細胞肺癌一線免疫治療的成本效果

Translated title of the contribution: Cost-effectiveness of First-line Immunotherapy for Non-small Cell Lung Cancer

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness of First-line Immunotherapy for Non-small Cell Lung Cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases